MASSDEVICE ON CALL — Medical device startups in New England appear to be enjoying a venture capital renaissance as their peers around the nation are forced to tighten their belts and look for alternative funding.
Local companies raked in more than $500 million through 46 listed deals last year, setting a new 10-year high, and 2013 is on track to match, the Boston Business Journal reported.
The average size of deals has also increased for New England, from about $8.2 million in 2007 to $11 million in 2012 and $15 million so far in 2013, according to the report.
Elsewhere in the U.S., medical device startups are facing a severe drop in VC availability compared with 5 years ago. Annual VC dollars have been less and less available year after year, and the latest projections put 2013’s total value at about $2.1 billion, down some 40% since 2007.
That means medtech startups are searching for unorthodox ways to fill their coffers, including by asking family members and local celebrities to kick in some cash
The dearth of funding has sent medtech startups in search of buyers earlier and earlier in their growth, and some of the industry’s biggest players are happy to comply. Boston Scientific (NYSE:BSX) corporate business development vice president Charlie Attlan has said that the giant is forming relationships with ever-younger companies.
Covidien donates $50k to Philippines relief efforts
Healthcare giant Covidien (NYSE:COV), which has employees and offices in the Philippines, donated $50,000 to relief efforts in the storm-ravaged country, half through a corporate grant to the Philippines Red Cross and the rest in donated products.
Medtronic, Lilly Diabetes team-up is 1st of its kind
Medtronic (NYSE:MDT) and Lilly Diabetes teamed up to become the 1st "national presenting sponsors" for the JDRF Walk to Cure Diabetes, helping to fund more than $500,000 in research for Type I diabetes.
High risk-to-benefit ratio for kidney disease patients seeking weight-loss surgery, study says
New research unveiled by the American Society of Nephrology says that bariatric surgery is an effective weight-loss option for patients with kidney disease, but the side effects and complication rates are higher, including increased risks of acute kidney injury, leak and acidosis.
Magnetic EKG may help docs diagnose, treat lethal heart rhythm in utero
The American Heart Assn. announced that new research suggests physicians may be able to use magnetic EKG to examine gestating babies to diagnose and treat long QT, a serious and potentially deadly heart condition that generally can’t be diagnosed until after birth.